Oral health is linked to overall health yet more than 56 million Americans live without access to a dental professional.
To continue to address the gaps in our oral health care system, CareQuest Innovation Partners in partnership with MATTER continues SMILE Health — a program designed to identify and accelerate early stage startups driving change in the systemic health landscape.
Join the dean of Harvard Dental School, Dr. William V. Giannobile, for a conversation with chief innovation officer of CareQuest Innovation Partners, Mariya Filipova as they discuss our current oral health system, bridging the gap between oral and overall health, ways to make oral health more accessible and equitable and the launch of SMILE Health.
Following the discussion, learn about SMILE Health, a first-of-its-kind program seeking early-stage startups to deliver disruptive solutions to improve overall health. We’ll discuss how to apply, partnership opportunities and more.
9:00-9:05am CT | Welcome remarks
PART 1: INSIGHTS ON ACCESSIBLE, EQUITABLE AND INTEGRATED ORAL HEALTH
PART 2: INSIGHTS INTO THE SMILE HEALTH PROGRAM
Mariya Filipova, MBA
Chief Innovation Officer | CareQuest Innovation Partners
Mariya Filipova is the chief innovation officer of CareQuest Innovation Partners. In her role, she oversees innovation, incubation, and investment activities aimed at developing solutions that advance oral health access, equity, and integration for underserved populations.
Formerly vice president of innovation at Anthem Inc., Mariya led efforts in scaling emerging technologies and new business models to accelerate Anthem’s transformation to a digital-first enterprise. Mariya’s vision and leadership in these areas resulted in the development of several breakthrough solutions and programs, including the $5 million XPRIZE Rapid COVID-19 Testing competition (in partnership with seven Blue Cross Blue Shield plans) to identify and validate fast, frequent, cheap, and easy-to-use testing solutions for SARS-CoV-2, and Anthem’s Digital Data Sandbox — among the largest certified de-identified commercial data sets.
Mariya served as one of the founding members of the Health Utility Network, a coalition of insurance companies, hospital networks, financial services, and technology companies developing blockchain solutions for health care. Prior to Anthem, Mariya drove the development of Deloitte’s Future of Work Center of Excellence, a portfolio of investments across the Americas, APAC, and EMEA that used exponential technologies (e.g., blockchain and artificial intelligence) to redefine the future of work. Mariya has also been recognized by Business Insider (“Insider’s 30 under 40”) and the Harvard Business School Association of Boston.
Mariya holds a master of business administration degree from Harvard Business School and a bachelor’s in economics, summa cum laude, from Mount Holyoke College.
Dr. William V. Giannobile
Dean | Harvard School of Dental Medicine
Dr. William Giannobile, dean of Harvard School of Dental Medicine (HSDM), is a leader in the field of periodontology and an internationally recognized scholar in oral regenerative medicine, tissue engineering, and precision medicine. He is an alumnus of HSDM, with an advanced degree in periodontology and oral biology. In September, 2020, he was appointed the 11th dean of HSDM.
Prior to HSDM, he served as the Najjar Endowed Professor and chair of the Department of Periodontics and Oral Medicine at the University of Michigan School of Dentistry. He was also a professor of biomedical engineering at the College of Engineering and Biointerfaces Institute. He received his DDS and MS in oral biology from the University of Missouri. He later received his certificate in periodontology and Doctor of Medical Sciences in oral biology from the Harvard School of Dental Medicine. He completed postdoctoral training in molecular biology at the Dana-Farber Cancer Institute and Harvard Medical School. Dr. Giannobile previously held positions as a faculty member at HSDM as an assistant professor of Periodontology and at the Forsyth Institute. He has served as a visiting professor at the University of Genoa Medical School Biotechnology Institute and the Eastman Dental Institute, University College London.
Giannobile’s research focuses on oral and periodontal regenerative medicine, tissue engineering and precision medicine. He has maintained a continuously NIH-funded research program over the past 25 years, and serves as co-principal investigator for the NIDCR-supported Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center. The goal of the center is to translate early stage dental, oral and craniofacial reconstructive technologies into clinical practice. He has produced over 300 manuscripts, textbook chapters, and patents focused on periodontology, regenerative medicine and oral health research. He is the editor or co-editor of nine books focused on clinical, translational research, periodontology and regenerative medicine. Giannobile recently completed a ten-year term as the editor-in-chief for the Journal of Dental Research, the official journal of the International Association for Dental Research. Giannobile is also a consultant to the U.S. Food and Drug Administration for Dental Devices. He served as an associate editor for the report on the Surgeon General’s Report on Oral Health – 2020.
In 2018, Giannobile received the American Dental Association’s Norton Ross Award for Excellence in Clinical Research. He is also a recipient of the Distinguished Scientist Award from the Academy of Periodontology. He is a fellow of the American Association for the Advancement of Science, the American Association for Dental Research and the International and American Colleges of Dentists. He is a past president of the American Academy of Periodontology Foundation, and currently serves as the president of the Osteology Foundation, an organization devoted to oral tissue regeneration by the promotion of science and clinical practice. In addition to his research efforts, he is involved in clinical and didactic teaching in periodontology and practices clinically in periodontics and implant dentistry at the Harvard Dental Center.